At Pfizer, we believe our business and societal missions are the same: ensuring all individuals everywhere have access to quality medicines, vaccines and health care, and the opportunity to lead healthy lives. Every day, we strive to use our full resources – our people, products and funding – to find new ways to positively impact the health of people around the world and across their lifespan.
Historically, the private sector has focused on traditional philanthropic approaches of large-scale cash and product donations to address global health needs. However, against the backdrop of a dramatically changing world, companies like Pfizer are also changing their approach to global health. We now aim to build on our current footprint of programs with new approaches and solutions that reflect the unique needs of each community – and ultimately accelerate the impact we can have on the health of all people around the world.
To achieve these goals, we must be able to reach patients who are in need faster and build sustainable infrastructure – while being careful not to compromise quality or safety. We also know efficiency must be balanced with evidence of effectiveness. As such, we work with our partners to take a measured approach, using our analytics and research resources to collect outcomes data before launching at scale. Nearly all of our initiatives to improve global health begin as pilot programs; only after careful evaluation of effectiveness and consideration of local nuances do we expand our programs to serve a broader population.
Learn more about how we are accelerating patient impact and improving global health: www.pfizer.com/annual.
KEYWORDS: Health & Healthcare, Pfizer, reports, Partnerships, philanthropy, annual review, access, entrepreneurship, medicines, vaccines, Corporate Social Responsibility